PCSK9 and Alzheimer disease: It is likely that all the hypocholesterolemic pharmacological tools which modulate circulating PCSK9 levels or its functioning are suitable to prevent the effects through which elevated blood cholesterol levels contribute to BBB and brain injuries, limiting AD development.